Skip to main content
. 2020 Apr 14;2020(4):CD010599. doi: 10.1002/14651858.CD010599.pub2

Wimmersberger 2018.

Methods Design: parallel group randomized trial
Follow‐up: 21 days
Participants Country: République de Côte d'Ivoire
Setting: rural school from 7 village
Age: 2–12 years
Sex: 46% girls
Number included in study: 302
Inclusion criteria: children with T trichiura infection intensities of > 60 epg of stool in preschool aged and 100 epg in school age
Exclusion criteria: children with any systemic illness (e.g. symptomatic malaria, severe anaemia defined as haemoglobin < 70 g/L in preschool‐aged and < 80 g/L in school‐aged children, underwent any anthelminthic treatment within the past 4 weeks, or were allergic to ivermectin
Follow‐up: 10 (3.3%)
Number positive for A lumbricoides: 79
Number included in review: 79
Interventions Treatment strategy: screening and treat all included participants
Children aged 2–5 years
  • Group 1: ivermectin 100 μg/kg single dose (n = 14)

  • Group 2: ivermectin 200 μg/kg single dose (n = 9)

  • Group 3: placebo single dose (n = 10)


Children aged 6–12 years
  • Group 4: ivermectin 200 μg/kg single dose (n = 14)

  • Group 5: ivermectin 400 μg/kg single dose (n = 13)

  • Group 6: ivermectin 600 μg/kg single dose (n = 8)

  • Group 7: placebo (n = 11)

Outcomes Outcomes included:Ascaris prevalence pre‐ and post‐treatment, cure rates, GM epg, adverse events
Outcomes not included in review: anthelmintic efficacy for Trichuris, hookworm, andS mansoni
Notes Diagnostic technique: Kato‐Katz
Funding support: Bill and Melinda Gates Foundation (Grant number: OPP1153928)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "Randomization was done using a computer‐generated code with varying random blocks sizes of four or eight for school aged children and of three or six for pre school aged children stratified by their baseline infection intensities (light or moderate plus heavy infection according to WHO guidelines."
Allocation concealment (selection bias) Unclear risk Details not reported.
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Quote: "Study‐site investigators were aware of the study‐group assignment."
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Quote: "laboratory technicians were blinded."
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 10 (3.3%) participants lost at follow‐up and not included in analysis.
Selective reporting (reporting bias) Low risk All stated outcomes were reported.
Other bias Low risk No obvious source of other bias.